Skip to content

Home / Knowledge hub / Aseptic injectable fill-finish facility

Aseptic injectable fill-finish facility

March 22, 2024

Through strategic investments and expansions, Kindeva Drug Delivery is on the forefront of combination product innovation. Our aseptic injectable fill-finish facility in Bridgeton, Missouri, is one example of our commitment to excellence. With the addition of this facility, we are one of only a few CDMOs capable of servicing sterile fill, device manufacture, and final assembly in one geographic location.  

Download our information sheet to explore our Bridgeton facility’s features, including: 

  • Annex 1 compliance with every line 
  • Integrated capabilities for injectable combination product development and manufacturing 
  • Our microBatch isolated filling line (batch sizes <2,500) 
  • Unrivaled capacity across vials, cartridges, and syringes 
  • How our key design principles of quality, scale, automation, and efficiency enable reliable delivery on your product’s timeline  
View Resource

Related resources

Explore our other resources to discover valuable insights on the latest trends in drug delivery.

From vial to value: How GLP-1s are redefining injectable care for chronic conditions

The market for glucagon-like peptide-1 (GLP-1) therapies is growing rapidly, with a projected value of $186.6 billion by 2032. Originally developed for diabetes, these therapies are now widely used for obesity treatment, which has created a need for convenient and scalable delivery systems. This growth is reshaping the industry, creating new demands on manufacturing capacity […]

Learn More

A bridge to the future: Our world-class Bridgeton facility

Manufacturing sterile injectables today is more complex than ever. Navigating stringent aseptic requirements, evolving regulatory expectations and the need for significant specialized investment has made the path to market increasingly challenging. A fragmented approach across development, drug substance manufacturing and fill finish remains a common industry practice that can introduce critical vulnerabilities. With every handoff, […]

Learn More

Sterile product introduction and​ tech transfers in a crowded market

The tech transfer landscape for sterile products is increasingly complex, with pressure to reduce time to market. Find out how to navigate common challenges and avoid costly delays or oversights in this presentation from our Director, Client Portfolio & Relationship Management, Kim Brown.  Download your copy to explore:  Benefits of a commercial manufacturing mindset  How […]

Learn More

Let’s transform tomorrow together

Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.